145 related articles for article (PubMed ID: 22179626)
1. Innovation in biotechnology: current and future states.
Woollett GR
Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626
[TBL] [Abstract][Full Text] [Related]
2. Europe caught in innovation quagmire.
Mitchell P
Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
[No Abstract] [Full Text] [Related]
3. The development of China's medical biotech industry needs to be driven by innovation.
Yu Z; Dai Y
Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
[TBL] [Abstract][Full Text] [Related]
4. Innovation drives success in Switzerland's biotech scene.
Whyte B
Drug Discov Today; 2005 Oct; 10(20):1342-5. PubMed ID: 16253869
[No Abstract] [Full Text] [Related]
5. Biotech as Bush bows out.
Lorenzo A
Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
[No Abstract] [Full Text] [Related]
6. The promise of South African biotech.
Akermann B; Kermani F
Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
[No Abstract] [Full Text] [Related]
7. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
Närhi M; Nordström K
Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
[TBL] [Abstract][Full Text] [Related]
8. An industry imperiled by regulatory bottlenecks.
Naughton G
Nat Biotechnol; 2001 Aug; 19(8):709-10. PubMed ID: 11479550
[No Abstract] [Full Text] [Related]
9. Innovation and compliance are not diametrically opposed.
Raab GK
Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614
[No Abstract] [Full Text] [Related]
10. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Reed SD; Califf RM; Schulman KA
Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
[TBL] [Abstract][Full Text] [Related]
11. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
Hakim Z; Kucukarslan S
Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
[TBL] [Abstract][Full Text] [Related]
12. GlaxoSmithKline pushes its labs towards 'biotech' future.
Adam D
Nature; 2001 Mar; 410(6824):5. PubMed ID: 11242002
[No Abstract] [Full Text] [Related]
13. Biotech boom.
Jayaraman KS
Nat Biotechnol; 2005 Sep; 23(9):1183-4. PubMed ID: 16151411
[TBL] [Abstract][Full Text] [Related]
14. [Biopharmaceutical industry's commitment to innovation and to the future of health care].
Marini G
Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719
[TBL] [Abstract][Full Text] [Related]
15. The patentability of antibodies in the United States.
Lu DL; Collison AM; Kowalski TJ
Nat Biotechnol; 2005 Sep; 23(9):1079-80. PubMed ID: 16151395
[TBL] [Abstract][Full Text] [Related]
16. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
17. As biotech turns 20..
Miller HI
Nat Rev Drug Discov; 2002 Dec; 1(12):1007-8. PubMed ID: 12461522
[TBL] [Abstract][Full Text] [Related]
18. The two-curve problem: high-risk challenges face those who plan a hospital's future.
Morrison JI
Health Manage Q; 1994; 16(1):11-5. PubMed ID: 10133736
[No Abstract] [Full Text] [Related]
19. Evolution and future of biopharmaceuticals.
Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
[No Abstract] [Full Text] [Related]
20. Growing pains for biopharmaceuticals.
Ashton G
Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
